Search results
Dr. Gillis is a biotech entrepreneur and immunologist with over 300 publications and multiple marketed products. He is a director of several ARCH portfolio companies and Takeda Pharmaceuticals.
- Contact
1700 Owens St., Suite 535 San Francisco, CA 94158. COMPANY....
- Contact
Our Team. We are contrarian. We are bold. We are imaginative risk takers.
Dr. Gillis is a Managing Director at ARCH and a Board Chairman at Bitterroot Bio, a biotechnology company developing novel immunotherapies. He is also a Director of several other biotech companies and a pioneer in the field of cytokines and cytokine receptors.
Apr 2, 2020 · Steve Gillis is one of the Managing Directors of ARCH Venture Partners, a leading early stage technology venture firm. He is involved in investing in transformative biotechnology companies and advancing science to impact human health.
Dr. Steven Gillis is a managing director at ARCH Venture Partners, focused on the evaluation of new life science technologies and the development and growth of ARCH’s biotechnology portfolio companies.
Steve Gillis is a biotechnology and pharmaceutical sector expert with over 20 years of venture capital experience. He is a founder and director of several life science companies, including Corixa, Immunex and Trubion.
Dr. Steven Gillis is a managing director with ARCH Venture Partners, joining the firm in 2005. Dr. Gillis is focused on the evaluation of new life science technologies and also on the development and growth of ARCH’s biotechnology portfolio companies.
